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A new era in surgery has emerged.[1] A discipline faced with multi­
ple challenges in the universal health coverage environment is 
discovering how to integrate surgical care provision into the global 
health agenda. The traditional perception that surgery is less cost­
effective than other available interventions, such as medicines or 
public health interventions, is being challenged by new emerg­
ing evidence suggesting that surgery can represent good value 
for money. [2] Surgical care is not a pathology­based intervention, 
but rather a dynamic system that has a crucial role to play in 
managing the burden of disease, including communicable and non­
communicable diseases.
Several recent developments have highlighted the crucial role 
of surgery in the health system. The 2015 World Health Assembly 
resolution 68.15 outlined the importance of ‘Strengthening 
emergency and essential surgery and anaesthesia care as a component 
of universal health coverage.’[3] In addition, the Lancet Commission 
on Global Surgery 2030 synthesised much of the evidence supporting 
the role of surgery and modelled a number of scenarios.[4] Key 
messages from these developments reflecting the role of surgery 
globally and the consequence of failure to address the unmet surgical 
need are:
• 5 billion people cannot access safe surgery when needed
• 33 million individuals face catastrophic expenditures paying for 
surgery and anaesthesia annually
• Investing in surgery is affordable, saves lives, and promotes 
economic growth.
In South Africa (SA), there is a need to develop a care package 
for the different levels of service delivery in the public health 
system, including a package for district hospitals. Developing these 
packages requires an understanding of the economic implications of 
intervention implementation. The content of these packages could 
then inform the development of a national surgical plan.
The success of an initiative focused on developing and implemen­
ting surgical care packages at different levels of care will be deter­
mined by many factors, including the ability of educational institu­
tions to facilitate the skills transfer of appropriate competencies, and 
the availability of appropriate infrastructure and systems to allow the 
delivery of the different care packages.
Surgical care is strongly linked to technology. There is a flood of 
new technologies and innovation in the surgical care environment, 
and determining the appropriate intervention for the right setting 
requires an evidence­based evaluation of the technologies. The 
spectrum of interventions that could be considered appropriate 
ranges from low­technology­driven procedures with a wide reach 
that can be offered to patients at primary care level, to high­end 
technologies that can only be performed at tertiary care level.
So what surgical options should we offer? This question is at 
the heart of priority setting, which draws on the best traditions 
of evidence­based medicine, health economics and medical 
ethics, and can help us to identify what health interventions and 
technologies can and should be offered to people under a universal 
health coverage system in SA under the rubric of National Health 
Insurance (NHI). It is through the use of formal processes and 
methods that reasoned and defensible decisions can be made about 
investment and implementation of low­ and high­cost surgical 
procedures.
Priority setting allows us to identify the surgical ‘best buys’ for 
SA based on a review of available evidence and to support and 
ensure appropriate utilisation of resources. Best buys are packages 
of interventions, services and/or policies that could be implemented 
within a particular programme area given available resources and 
health­systems constraints. For example, the role of laparoscopic 
surgery in the management of appendicitis or hernia repairs needs to 
be determined in SA contexts. Utilising health technology assessment 
(HTA) and priority setting, we can achieve the best use of resources, 
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and include the most cost­effective surgical interventions regardless 
of their level of complexity.
Priority setting, HTA and surgery
PRICELESS SA (Priority Cost Effective Lessons in Systems Strength­
ening, www.pricelesssa.ac.za) is a research­to­policy programme 
that uses SA data to demonstrate how scarce resources can be used 
to derive maximum impact on health. To demonstrate the potential 
benefits of priority setting, PRICELESS SA works to identify best 
buys, using HTA to ensure that limited resources are targeted towards 
interventions, policies and programmes that will offer the greatest 
health gain across the population. For example, by prioritising 
15 maternal and child health interventions we identified as best buys, 
the lives of an additional 10 000 mothers and newborns per year in 
SA could be saved at a cost of USD7 per capita.[5]
The principle of best buys and identifying cost­effective 
inter ventions can be applied across any programme area and 
setting, including surgery. Investigations of cost­effective surgical 
interventions relative to neglected tropical diseases across sub­
Saharan Africa found that basic surgical services, emergency 
obstetric surgery, and surgical management of fractures, soft­tissue 
trauma and some cancers were relatively cost­effective compared 
with other prioritised interventions in the region.[6] Researchers 
have demonstrated that surgical management of acute appendicitis 
represents relatively good value for money in SA, at approximately 
USD1 700 per life­year saved.[7] Additional cost­effectiveness 
research is required, especially with regard to the availability and 
utilisation of elective surgical procedures as a treatment option, 
the availability of which is often linked with socioeconomic status 
(SES). For example, cataract surgery coverage in Cape Town was 
68% in areas associated with the lowest SES compared with 100% 
in areas with the highest SES. This is one example of how priority 
setting could inform policy and planning decisions across the health 
system – by showing how to deploy scarce resources effectively to 
address avoidable blindness.[8]
Although a consistent approach to establishing best buys and 
priority setting in surgery has not yet been established, progress 
towards NHI is likely to make this a reality. The White Paper on NHI 
released in 2015[9] and revised in 2017[10] indicated the important 
role HTA will play in the prioritisation, selection, distribution 
and management of medicines, devices and interventions. HTA 
will empower policy­makers to make the most efficient use of 
resources. The term HTA and associated concepts are used frequently 
in discussions about resource allocation improvement, so it is 
instructive to define it here. According to the International Society for 
Health Technology Assessment, HTA is a ‘field of scientific research 
to inform policy and clinical decision making on the introduction 
and use of health technologies … HTA is a multidisciplinary field 
that addresses the clinical, economic, organizational, social, legal, 
and ethical impacts of a health technology, considering its specific 
healthcare context as well as available alternatives’.[11] Importantly, 
technologies are defined broadly to mean pharmaceuticals, devices 
and procedures (including surgical procedures), as well as clinical, 
public health and service/organisational interventions. Put simply, 
HTA is the analysis of the costs and benefits of a health intervention, 
incorporating other relevant factors and then using the results of the 
analysis to make policy decisions. HTA is a useful tool to make an 
evidence­based case for surgery that might otherwise be perceived 
as too complex or expensive to implement – the same areas that 
are likely to represent the highest unmet need, and where we can 
get the biggest ‘bang for the buck’ from stretched health budgets. 
Importantly, HTA can be used to make the clinical, economic, social 
and common­sense case for investment in high­impact surgical 
interventions that are good value for money.
Priority­setting methods and processes can extend beyond an 
individual procedure to packages of care and service delivery 
platforms. For example, in some instances the most cost­effective way 
to provide highly specialised services may be to fund a smaller number 
of specialised hospitals providing limited ranges of procedures, but at 
a higher volume. However, over­specialisation of surgical staff in a 
context with limited human resources could lead to poorer overall 
outcomes and cost­effectiveness of services. SA policy and planning 
may need to consider alternative scenarios, for example by training 
clinical associates to perform a single procedure flawlessly, as is done 
in other middle­income settings.
Acknowledging unavoidable trade-
offs: Economists and surgeons
Priority setting, with its foundations in universal health coverage, 
takes a population­level approach. ‘Best buys’ defines ‘best’ as those 
interventions that can feasibly achieve the greatest health impact 
from available resources. Implicit in this approach is consideration of 
the opportunity cost: because budgets are fixed, the opportunity cost 
is the health gain that could be achieved elsewhere in the healthcare 
system had resources been used differently. All interventions involve 
resource use, whether it is time, money, or physical use of space. 
Priority setting is about weighing up these trade­offs and making an 
informed decision.
While terms such ‘opportunity cost’ and ‘trade­off ’ are traditionally 
the parlance of economists, surgeons are likely to innately understand 
the concept. Surgical training prepares them to evaluate likely 
benefits and harms of a procedure, communicate this to the patient, 
and decide on a course of action. At a population level, surgical 
triage aims to arrange patient flows and prioritise treatment to 
maximise collective patient benefit from available resources, 
implicitly incorporating opportunity costs into service planning and 
decision­making. Priority setting is no different, except that instead 
of being applied to an individual patient or group of patients at a 
single place and time, it occurs continuously and at population level, 
across multiple delivery platforms and potential interventions. In 
addition to hard science about likely benefits, harms and costs, and 
their relative uncertainty, active priority setting also allows decision­
makers to take into account the wider social values and health system 
objectives that are an inherent factor in many medical and resource 
allocation decisions.
A NICE approach
The National Institute for Health and Care Excellence (NICE) in 
the UK is a priority­setting institution that uses HTA to advise the 
National Health Service (NHS) on the use of particular interventions 
and technologies. The pros and cons of a NICE­like approach in 
SA have been debated,[12­14] with principal consideration in the 
literature given to the implication of applying cost­effectiveness/HTA 
decision rules to access and eligibility decisions and the feasibility of 
applying the NICE structure and institutional arrangements to the SA 
context. This literature suggests that while SA will need to develop 
locally appropriate institutional arrangements, individual lessons and 
experiences from NICE can provide a comprehensive understanding 
of how priority setting could be applied to surgical interventions.
For example, NICE guidance on gastro­oesophageal reflux disease 
(GORD) considered whether laparoscopic fundoplication should be 
routinely offered to patients suffering from reflux.[15] GORD patients 
are traditionally managed medically, but improvements in outcomes 
and safety of fundoplication techniques suggested that surgery might 
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be a more appropriate intervention. The NICE evaluation used 
established processes and methodological frameworks to compare 
laparoscopic fundoplication with medical management. The surgical 
option represented comparatively high up­front costs and potential 
risks, but provided superior long­term health and cost outcomes for 
many patients. Part of the evidence­review process was consideration 
by a multidisciplinary committee that included lay membership, 
which is especially important when assessing patient perceptions and 
experience of surgery. In addition, the committee considered whether 
laparoscopic surgery could routinely and safely be offered to the 
population in an equitable way, or whether a recommendation for use 
would only favour those near major surgical centres. After evidence 
collation and economic modelling, laparoscopic fundoplication 
was found to represent a good investment option for the NHS 
and met patient safety and equity­of­access considerations. NICE 
recommends that it now be offered routinely when individual patient 
characteristics warrant surgical intervention.
While management of reflux may not be a high priority in SA, 
the principles by which a robust and trusted priority­setting process 
might work are highly relevant to the proposed NHI environment.
HTA for surgery: Challenges
Traditionally, government institutions involved in explicit priority 
setting such as NICE in England, the Health Intervention and 
Technology Assessment Program in Thailand or the Pharmaceutical 
Management Agency of New Zealand started with assessments 
and decisions about pharmaceuticals. The reasons for this focus 
on pharmaceuticals vary, as the priority­setting journey is always 
unique, but a common factor is the tractability of the decision 
problem. HTA involves an assessment of the likely costs and effects 
of an intervention, and on a population level it is generally easier to 
isolate both the marginal spend and clinical effectiveness estimate of 
a pharmaceutical product compared with a surgical intervention. To 
apply HTA to surgery, we must ensure that we can accurately, reliably 
and consistently represent costs and effects of surgical interventions 
at population level. This will allow them to be considered on a 
level playing field with competing surgical interventions and other 
potential healthcare investments.
Surgical skill and experience, in addition to health system 
organisation and referral structures, has a direct impact on costs and 
patient outcomes, just as the clinical effect of a course of medication 
will vary depending on the prescribing physician, the service 
environment and patient compliance. Surgical costs can, however, be 
vastly different between centres depending on surgical techniques, 
case mix, patient throughput volumes and financing arrangements 
for capital equipment. For example, annual surgical cost in India was 
USD5 000 per bed in a 60­bed charity hospital, USD800 per bed in a 
400­bed, first­level public hospital, and USD2 000 per bed in a 655­
bed private teaching hospital; the high costs of the charitable hospital 
were attributed to expatriate staff and external funding.[16] This 
variation in costs and effects makes obtaining a central estimate and 
distribution challenging – a factor that can be overcome by improved 
data collection and management.
Another challenge to HTA for surgery is the uneven nature 
of the inputs (costs) and outputs (patient health). For a patient 
receiving medical treatment for a chronic condition, the costs (e.g. 
one tablet per day) and clinical outcomes are relatively consistent 
and predictable. In contrast, with surgery the costs and risks are 
mostly incurred up front, with clinical benefit often extending for 
many years, particularly for life­saving interventions. Again, this 
calculation issue can be overcome through the use of analytical 
techniques that take into account short­ and long­term effects 
and costs. It is, however, important to acknowledge this analytical 
challenge and the potential unacceptability to policy­makers with 
limited budgets to prioritise surgical investments that may represent 
a large ‘pay now, benefit later’ offer.
Using HTA to inform decisions on the use of surgical interventions 
and the appropriate level of care may also be challenging. In addition, 
once surgical services with their supporting infrastructure are in place, 
the estimates of the incremental cost­effectiveness of interventions 
will be affected (compared with facilities without this infrastructure), 
leading to inconsistent estimations of the cost­effectiveness of the 
interventions. These dilemmas require techniques to assess options 
for referral systems or different service delivery platforms, and for 
analyses that look more carefully at incremental and marginal costs 
rather than just average costs. While these approaches may add 
complexity to the analyses, the results enable more robust policy 
decisions on service availability and better resource use from primary 
to tertiary level, with better outcomes for patients.
Conclusion: Advancing priority 
setting for surgery
High­impact, low­cost surgical interventions may be a good use 
of limited health funds in SA. However, to make the case for 
the necessary investments, two key elements are required. Firstly, 
frameworks for accurately representing and analysing costs and clear 
outcomes for surgical interventions need to be developed. This is 
often seen as primarily an area for policy makers, but the surgical 
community must play its part in this process. The surgical community 
can contribute by conducting research to determine which surgical 
procedures account for better or worse balances between number of 
admissions, mortality, complications and costs on the one hand, and 
improvements in length and quality of life on the other. The second 
element that is required is the strengthening of priority­setting 
frameworks. This involves introducing processes and methods for 
analysing and deliberating the clinical and economic evidence, but 
also for more systematic consideration of social values such as the 
need to improve equity in access to health services. An important 
component of these processes will be to adopt a population­level 
perspective. This will ensure that opportunity costs of investments 
are understood and that optimal health outcomes are achieved from 
within available budgets. These frameworks would need to be applied 
across several programme areas and types of medical technology and 
intervention. However, it is certain that various surgical interventions 
would be considered good investments, strengthening the case for 
their implementation and ultimately improving the health of all 
South Africans.
Salient points
• There is a large unmet need for basic surgical interventions in 
many low­ and middle­income countries.
• Priority setting is a process by which decisions are made on health 
priorities based on evidence of potential benefit, risk, resource use 
and opportunity cost, in addition to consideration of values such 
as equity and fairness.
• HTA is a mechanism to synthesise, present and appraise the 
evidence required for priority setting.
• The case for high­impact, low­cost surgery in SA would be 
strengthened by an HTA approach, as well as establishment of an 
effective priority­setting system or agency.
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